journal
MENU ▼
Read by QxMD icon Read
search

Current Rheumatology Reports

journal
https://www.readbyqxmd.com/read/30008153/proteomics-in-chronic-arthritis-will-we-finally-have-useful-biomarkers
#1
REVIEW
Christoph Kessel, Angela McArdle, Emely Verweyen, Toni Weinhage, Helmut Wittkowski, Stephen R Pennington, Dirk Foell
PURPOSE OF REVIEW: Current technical advances enable the assessment of the complex changes in body fluid proteomes and thus allow for the discovery of biomarker signatures rather than just following differences of a single marker. In this review, we aim to summarize current approaches to discover and evaluate multi-biomarker panels for improved monitoring of chronic arthritis disease activity. RECENT FINDINGS: Mass spectrometry and affinity proteomic methodologies have been used to identify biomarker panels in synovial fluid, serum, plasma, or urine of pediatric and adult chronic arthritis patients...
July 14, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29955981/update-on-inclusion-body-myositis
#2
REVIEW
Duaa Jabari, V V Vedanarayanan, Richard J Barohn, Mazen M Dimachkie
PURPOSE OF REVIEW: While sporadic inclusion body myositis (sIBM) is the most common acquired muscle disease after age 50, the pathogenesis of this disease is still poorly understood. In this review, we discuss our current state of knowledge in sIBM and provide an update on our current understanding of its pathophysiology and management. RECENT FINDINGS: Lines of evidence in support of an inflammatory pathogenesis include inflammatory infiltrates in the target organ, NFκB activation, cytokine response, MHC I upregulation, and cN1A antibody...
June 28, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29951774/expression-and-metabolomic-profiling-in-axial-spondyloarthritis
#3
REVIEW
Darren D O'Rielly, Guangju Zhai, Proton Rahman
PURPOSE OF REVIEW: The purpose of this review is to highlight recent evidence with respect to expression and metabolomic profiling in axial spondyloarthritis (axSpA) that included ankylosing spondylitis (AS). RECENT FINDINGS: AxSpA is not only characterized by the strongest genetic contribution for any complex rheumatic disease but is also influenced by environmental and immunological factors. Large-scale association-based studies have identified over 100 genetic variants contributing to 30% of the genetic risk of ankylosing spondylitis...
June 27, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29946747/preclinical-rheumatoid-arthritis-and-rheumatoid-arthritis-prevention
#4
REVIEW
Kevin D Deane
PURPOSE OF REVIEW: This review is to provide an update on the current understanding of rheumatoid arthritis (RA) development related to disease development prior to the onset clinically apparent synovitis and opportunities for disease prevention. RECENT FINDINGS: A growing number of studies have demonstrated that serum elevations of autoantibodies rheumatoid factor and antibodies to citrullinated protein/peptide antigens (ACPA) are highly predictive of future development of IA/RA...
June 26, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29943234/update-on-the-gastrointestinal-microbiome-in-systemic-sclerosis
#5
REVIEW
Chiara Bellocchi, Elizabeth R Volkmann
PURPOSE OF REVIEW: Accumulating evidence suggests that gut microbiota affect the development and function of the immune system and may play a role in the pathogenesis of autoimmune diseases. The purpose of this review is to summarize recent studies reporting gastrointestinal microbiota aberrations associated with the systemic sclerosis disease state. RECENT FINDINGS: The studies described herein have identified common changes in gut microbial composition. Specifically, patients with SSc have decreased abundance of beneficial commensal genera (e...
June 25, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29943203/optimizing-rheumatoid-arthritis-patients-for-surgery
#6
REVIEW
Alana Sigmund, Linda A Russell
PURPOSE OF REVIEW: The purpose of this review is to guide providers on how best to optimize the health of patients with rheumatoid arthritis (RA) planning surgery, to reduce risk and complications and achieve the best outcomes. RECENT FINDINGS: The American College of Rheumatology (ACR) and the American Association of Hip and Knee Surgeons (AAHKS) have issued a recent guideline on perioperative management of antirheumatic medications in patients with RA. Patients with RA will continue to need surgery...
June 25, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29931553/predicting-response-or-non-response-to-urate-lowering-therapy-in-patients-with-gout
#7
REVIEW
Garry G Graham, Sophie L Stocker, Diluk R W Kannangara, Richard O Day
PURPOSE OF REVIEW: To review the extent of treatment success or failure with the xanthine oxidoreductase inhibitors allopurinol and febuxostat and indicate how the dosage of urate-lowering therapy (ULT) may be modified to increase the response in the majority of patients with gout. RECENT FINDINGS: Gout flares are associated with serum concentrations of urate above 0.42 mmol/L (7 mg/dL). Achieving and maintaining serum urate below 0.36 mmol/L is considered an effective response to ULT...
June 21, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29931429/better-quantification-of-syndesmophyte-growth-in-axial-spondyloarthritis
#8
REVIEW
Michael M Ward, Sovira Tan
PURPOSE OF REVIEW: We review new insights to syndesmophyte growth in axial spondyloarthritis revealed by computed tomography (CT). RECENT FINDINGS: CT allows full reliable quantitation of syndesmophytes. About 70% of patients had detectable growth in syndesmophyte volume or height in 1 year. Syndesmophyte growth is not uniform, but can be highly heterogeneous even within the same disc space of the same patient. Syndesmophytes are not randomly distributed around the vertebral rim but have preferred locations (posterolateral and anterolateral) which vary along the spine...
June 21, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29900477/the-use-of-biosimilars-in-the-middle-east-review-article
#9
REVIEW
Nazar AbdulLateef Jassim, Yasameen Abbas Humadi
PURPOSE OF REVIEW: Biosimilars are of growing importance worldwide, and many leading countries are introducing them in their health care systems and are using them in many fields of medicine owing to their low price tags in comparison with the brands and to their similarities in terms of function and side effects. So we cannot look past them and continue to rely on the innovator drugs since many had proven their efficacies in number of researches and Trials, not to mention the burden that many diseases pose on the budgets of the third world countries making using a lower priced alternatives a much appealing choice for the decision makers...
June 13, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29850957/thrombosis-and-anti-phospholipid-syndrome-a-5-year-update-on-treatment
#10
REVIEW
Cecilia Beatrice Chighizola, Pier Luigi Meroni
PURPOSE OF REVIEW: The aim of this review is to provide an update of the therapeutic tools for thrombotic anti-phospholipid syndrome (APS), focusing on the last 5 years. RECENT FINDINGS: Early studies appointed anticoagulation at moderate intensity as the mainstay of treatment of thrombotic APS; in the last 5 years, the strategy has not much mutated. Some uncertainties regarding the role of direct oral anticoagulants and the optimal regimen for arterial thrombotic APS still persist: high-intensity anticoagulation, anticoagulation plus anti-platelet agent, and double anti-platelet agents being the possible alternatives...
May 31, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29846841/an-update-on-autoinflammatory-diseases-relopathies
#11
REVIEW
Annemarie Steiner, Cassandra R Harapas, Seth L Masters, Sophia Davidson
PURPOSE OF REVIEW: The nuclear factor κB (NF-κB) pathway is tightly regulated through multiple posttranslational mechanisms including ubiquitination. Mutations in these regulatory pathways can cause disease and are the focus of this review. RECENT FINDINGS: The linear ubiquitin chain assembly complex (LUBAC) is a trimer made up of HOIL-1L, SHARPIN, and the catalytic subunit HOIP. Loss of function mutations in HOIL-1L and HOIP result in largely overlapping phenotypes, characterized by multi-organ autoinflammation, immunodeficiency, and amylopectinosis...
May 30, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29846828/cns-vasculitis-an-approach-to-differential-diagnosis-and-management
#12
REVIEW
Kevin Byram, Rula A Hajj-Ali, Leonard Calabrese
PURPOSE OF REVIEW: The goal of this review is to provide an up-to-date approach to diagnosis and management of patients with central nervous system (CNS) vasculitis. RECENT FINDINGS: Challenges in diagnosis of CNS vasculitis still exist due to the broad differential diagnosis and generally nonspecific initial clinical manifestations. Differentiation between primary angiitis of the CNS (PACNS) and secondary causes is important in guiding management. Recent longitudinal cohort studies have improved our understanding of PACNS...
May 30, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29846825/novel-therapeutics-in-psoriatic-arthritis-what-is-in-the-pipeline
#13
REVIEW
Ofir Elalouf, Vinod Chandran
PURPOSE OF REVIEW: To highlight the recently approved therapeutic agents in psoriatic arthritis (PsA), drugs in the pipeline, as well as to discuss efficacy with regard to different clinical domains of PsA. RECENT FINDINGS: More than 15 years ago, tumor necrosis factor inhibitors (TNFi) were the first biologic disease modifying anti-rheumatic drugs (bDMARDs) that were approved for the treatment of PsA. Since then, multiple new therapeutic agents inhibiting other targets have emerged including biologics targeting interleukin (IL) 12/23, and IL 17 and oral agents targeting phosphodiesterase 4 (PDE4) and Janus kinases (JAKs)...
May 30, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29846819/an-update-on-autoinflammatory-diseases-inflammasomopathies
#14
REVIEW
Cassandra R Harapas, Annemarie Steiner, Sophia Davidson, Seth L Masters
PURPOSE OF REVIEW: Autoinflammatory diseases are driven by abnormal innate immune activation. In the case of inflammasomopathies, these are all attributable to activation of an inflammasome complex, nucleated by an innate immune sensor such as NLRP3. This review will focus on recent advances that have helped to elucidate the role of three other sensors (NLRP1, NLRC4 and pyrin) which can also cause inflammasomopathies. RECENT FINDINGS: Mutations in pyrin (S242R or E244K) destroy an inhibitory 14-3-3 binding site and result in the newly characterised disease pyrin-associated autoinflammation with neutrophilic dermatosis (PAAND)...
May 30, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29846818/an-update-on-autoinflammatory-diseases-interferonopathies
#15
REVIEW
Sophia Davidson, Annemarie Steiner, Cassandra R Harapas, Seth L Masters
PURPOSE OF REVIEW: Type I interferons (IFNαβ) induce the expression of hundreds of genes; thus, it is unsurprising that the initiation, transmission, and resolution of the IFNαβ-mediated immune response is tightly controlled. Mutations that alter nucleic acid processing and recognition, ablate IFNαβ-specific negative feedback mechanisms, or result in dysfunction of the proteasome system can all induce pathogenic IFNαβ signalling and are the focus of this review. RECENT FINDINGS: Recent advances have delineated the precise cytoplasmic mechanisms that facilitate self-DNA to be recognised by cGAS and self-RNA to be recognised by RIG-I or MDA-5...
May 30, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29846817/epidemiology-of-psoriasis-and-psoriatic-arthritis-in-italy-a-systematic-review
#16
REVIEW
Francesca Prignano, Veronica Rogai, Elisabetta Cavallucci, Alessandro Bitossi, Volker Hammen, Fabrizio Cantini
PURPOSE OF REVIEW: Understanding prevalence of diseases within specific regions of a country is important for optimal allocation of healthcare resources/funds. We performed a systematic review to obtain a clearer picture of the epidemiology of psoriasis and psoriatic arthritis across and within specific regions of Italy. RECENT FINDINGS: Prevalence of psoriasis in specific regions showed more variability (0.8-4.5%) than that in the total population (1.8-3.1%). Prevalence of psoriatic arthritis in the general population was reported for only two regions, Chiavari (0...
May 30, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29846815/enthesitis-much-more-than-focal-insertion-point-inflammation
#17
REVIEW
Abdulla Watad, Richard J Cuthbert, Howard Amital, Dennis McGonagle
PURPOSE OF REVIEW: Recognition of the importance of enthesitis as the pivotal pathological process underpinning spondyloarthropathies (SpA) has increased in recent years. Thus, we summarized the current knowledge on the pathogenic role of enthesitis on SpA shown by both animal models and human studies in vivo. RECENT FINDINGS: Experimental models have shown several SpA-like diseases that commence at entheses and are linked to nail disease as well as dactylitis, two important entheseal-associated conditions in humans...
May 30, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29846814/cardiovascular-safety-of-biologics-and-jak-inhibitors-in-patients-with-rheumatoid-arthritis
#18
REVIEW
Eun Ha Kang, Katherine P Liao, Seoyoung C Kim
PURPOSE OF REVIEW: Increased cardiovascular (CV) risk and associated mortality in rheumatoid arthritis (RA) are not fully explained by traditional CV risk factors. This review discusses the epidemiology and mechanisms of increased CV risk in RA and treatment effects on CV risk focusing on biologic disease-modifying anti-rheumatic drugs (DMARDs) and JAK inhibitors. RECENT FINDINGS: Intermediary metabolic changes by inflammatory cytokines are observed in body composition, lipid profile, and insulin sensitivity of RA patients, leading to accelerated atherosclerosis and increased CV risk...
May 30, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29754330/gender-differences-in-axial-spondyloarthritis-women-are-not-so-lucky
#19
REVIEW
T Rusman, R F van Vollenhoven, I E van der Horst-Bruinsma
PURPOSE OF REVIEW: Ankylosing spondylitis (AS) was historically seen as a predominantly male disease. However, more recent data showed a more homogenous sex prevalence. Unfortunately, in many studies in axial spondyloarthritis (axSpA), the number of women included is low and the analyses are often not stratified for gender distribution. The purpose of this review is to aggregate the existing data on gender differences in axSpA in order to increase the awareness that female axSpA patients are still under-recognized...
May 12, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/29725880/new-trials-in-lupus-and-where-are-we-going
#20
REVIEW
Aikaterini Thanou, Joan T Merrill
PURPOSE OF REVIEW: To review progress in the field of clinical trials for SLE. RECENT FINDINGS: Treatment development for SLE has been marked by failures of many later phase studies, representing billions of dollars of lost research and development funding. Recently, more successful Phase II trials have tested reductions in background medications, novel stringent endpoints, and identification of informative immunologic subsets to achieve greater treatment effects...
May 3, 2018: Current Rheumatology Reports
journal
journal
34704
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"